AU648800B2 - Immune suppressive product - Google Patents

Immune suppressive product

Info

Publication number
AU648800B2
AU648800B2 AU78916/91A AU7891691A AU648800B2 AU 648800 B2 AU648800 B2 AU 648800B2 AU 78916/91 A AU78916/91 A AU 78916/91A AU 7891691 A AU7891691 A AU 7891691A AU 648800 B2 AU648800 B2 AU 648800B2
Authority
AU
Australia
Prior art keywords
milk
allergen
animal
active
allergens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU78916/91A
Other languages
English (en)
Other versions
AU7891691A (en
Inventor
Lee R. Beck
Ralph J. Stolle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stolle Milk Biologics Inc
Original Assignee
Stolle Research and Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Research and Development Corp filed Critical Stolle Research and Development Corp
Publication of AU7891691A publication Critical patent/AU7891691A/en
Application granted granted Critical
Publication of AU648800B2 publication Critical patent/AU648800B2/en
Assigned to STOLLE MILK BIOLOGICS, INC. reassignment STOLLE MILK BIOLOGICS, INC. Alteration of Name(s) in Register under S187 Assignors: STOLLE RESEARCH & DEVELOPMENT CORPORATION
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Dairy Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU78916/91A 1990-07-05 1991-04-26 Immune suppressive product Ceased AU648800B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54841990A 1990-07-05 1990-07-05
US548419 1990-07-05
PCT/US1991/002923 WO1992000756A1 (en) 1990-07-05 1991-04-26 Immune suppressive product

Publications (2)

Publication Number Publication Date
AU7891691A AU7891691A (en) 1992-02-04
AU648800B2 true AU648800B2 (en) 1994-05-05

Family

ID=24188777

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78916/91A Ceased AU648800B2 (en) 1990-07-05 1991-04-26 Immune suppressive product

Country Status (6)

Country Link
EP (1) EP0646017A1 (ja)
JP (1) JP3054194B2 (ja)
AU (1) AU648800B2 (ja)
CA (1) CA2086101C (ja)
NZ (2) NZ238117A (ja)
WO (1) WO1992000756A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
GB0002386D0 (en) * 2000-02-02 2000-03-22 Novartis Nutrition Ag Therapeutic composition
US7060687B2 (en) 2001-02-07 2006-06-13 Genmont Biotechnology Co. Live vaccines for allergy treatment
US20020197268A1 (en) * 2001-06-08 2002-12-26 Hsu Ching-Hsaing Allergen-containing milk for allergy treatment
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
JP2010532318A (ja) * 2007-04-16 2010-10-07 フリーズランド ブランズ ビー．ブイ． 乳に由来する抗原特異的抗体、それらの調製の方法及び使用方法
NL1033696C2 (nl) * 2007-04-16 2008-10-20 Friesland Brands Bv Aan melk ontleende antigeen-specifieke antilichamen, werkwijzen voor het bereiden en gebruik ervan.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU620289B2 (en) * 1988-04-04 1992-02-13 Stolle Milk Biologics, Inc. An anti-inflammatory factor, method of isolation, and use
AU621604B2 (en) * 1988-02-26 1992-03-19 Stolle Milk Biologics, Inc. Antihypertensive hyperimmune milk, production, composition, and use
AU8434091A (en) * 1990-09-11 1992-03-30 Stolle Milk Biologics, Inc. Anti-inflammatory factor, method of isolation, and use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
USRE33403E (en) * 1982-06-03 1990-10-23 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
AU590711B2 (en) * 1982-10-13 1989-11-16 Biowhittaker, Inc. Stable allergenic extracts and methods

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU621604B2 (en) * 1988-02-26 1992-03-19 Stolle Milk Biologics, Inc. Antihypertensive hyperimmune milk, production, composition, and use
AU620289B2 (en) * 1988-04-04 1992-02-13 Stolle Milk Biologics, Inc. An anti-inflammatory factor, method of isolation, and use
AU8434091A (en) * 1990-09-11 1992-03-30 Stolle Milk Biologics, Inc. Anti-inflammatory factor, method of isolation, and use

Also Published As

Publication number Publication date
CA2086101C (en) 2002-11-19
AU7891691A (en) 1992-02-04
WO1992000756A1 (en) 1992-01-23
EP0646017A4 (en) 1993-07-12
EP0646017A1 (en) 1995-04-05
CA2086101A1 (en) 1992-01-06
NZ238117A (en) 1996-01-26
NZ505179A (en) 2002-06-28
JP3054194B2 (ja) 2000-06-19
JPH05508397A (ja) 1993-11-25

Similar Documents

Publication Publication Date Title
EP0498854B1 (en) Antivenoms and methods for making antivenoms
CA1306946C (en) Specific antibody-containing substance from eggs and method of production and use thereof
JP3195631B2 (ja) 特異的鶏卵抗体の製造方法
FI98269C (fi) Menetelmä olennaisesti puhtaan tulehdusta estävän tekijän eristämiseksi maidosta
KR910005409B1 (ko) 계란으로 부터의 특이적항체함유재료의 제조방법
US5863561A (en) Immune suppressive product
AU648800B2 (en) Immune suppressive product
JP2792973B2 (ja) 抗高血圧過免疫ミルク、製法、組成物及び用途
JP2003521524A (ja) 乳中のアレルゲンの経口送達
AU660626B2 (en) Anti-inflammatory factor, method of isolation, and use
US7097845B2 (en) Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
JP2001526629A (ja) 卵の抗炎症性組成物、単離法および使用
CA2317813A1 (en) Composition and method for treatment and prevention of arthritis and/or autoimmune diseases
US6054124A (en) Immune suppressive product
Yonemasu et al. Antigenic specificities of delayed hypersensitivity in mice to dinitrophenylated proteins
JPH09315998A (ja) スギ花粉症の予防および／または治療剤
JPH07138187A (ja) 経口免疫寛容原、経口慢性関節リウマチ治療剤及び機能性食品
Alam et al. Production and properties of histamine-releasing factor of guinea pigs.
AU638786C (en) Antivenoms and methods for making antivenoms
CN1557836A (zh) 免疫抑制多肽的制备及应用
JPH0128A (ja) 馬用感染予防治療剤
UA128640C2 (uk) Спосіб одержання очищенного екстракту алергену
Harrison Development and Assessment of Avian and Ovine Antivenoms for European Viper Venoms
LAING et al. EXPERIMENTAL ASSESSMENT OF A NEW, LOW-COST ANTIVENOM FOR TREATMENT OF CARPET VIPER
BE554362A (fr) Procédé de fabrication d'un produit diététique physiologique pour nouveaux-nés et nourrissons

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired